Titre:
  • Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics
Auteur:Diéras, Veronique; Bonnefoi, Herve; Alba, Emilio; Awada, Ahmad; Coudert, Bruno; Pivot, Xavier; Gligorov, Joseph; Jager, Agnes; Zambelli, Stefania; Lindeman, Geoffrey G.J.; Charpentier, Eric; Emmons, Gary G.T.; Garcia-Ribas, Ignacio; Paridaens, R.; Verweij, Jaap W M J.
Informations sur la publication:Breast cancer research and treatment
Statut de publication:Publié, 2019
Sujet CREF:Cancérologie
Mots-clés:Administration schedule
Iniparib
Metastatic triple-negative breast cancer
Pharmacokinetics
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6806
info:doi/10.1007/s10549-019-05305-w
info:scp/85066982939